References
- Adachi JA, Jiang ZD, Mathewson JJ, Verenkar MP, Thompson S, Martinez-Sandoval F, et al. Enteroaggregative Escherichia coli as a major aetiological agent in traveller's diarrhoea in 3 regions of the world. Clin Infect Dis 2001; 32: 1706–9
- Bhan MK, Arora NK, Ghai OP, Ramachandran K. Major factors in diarrhea- related mortality among rural children. Indian J Med Res 1986; 83: 9–12
- Bhan MK, Raj P, Levine MM. Enteroaggregative Escherichia coli associated with persistent diarrhoea in a cohort of rural children in India. J Infect Dis 1989; 159: 1061–4
- Bern C, Martins J, Dezoysa I. The magnitude of the global problem of diarrhoeal diseases. A 10-y update. Bull World Health Organization 1992; 70: 705–12
- Cohen MB, Nataro JP, Bernstein DA, Hawkins J, Roberts N, Staat MA. Prevalence of diarrhoeagenic E. coli in acute childhood with diarrhoea. J Med Microbiol 2003; 52: 1015–9
- Huang DB, Okhuysen PC, Jiang Z, Dupont HL. Enteroaggregative Escherichia coli: emerging enteric pathogen. Am J Gastroenterol 2004; 99: 383–9
- Hoge CW, Ganmbel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrhoeal pathogens isolated in Thailand over 15 y. Clin Infect Dis 1998; 26: 341–5
- Carlson JR, Thornton SA, Dupont HL, West AH, Mathewson JJ. Comparative in vitro activities of 10 antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother 1983; 24(24)509–13
- Nataro JP, Mai V, Johnson J, Blackwelder WC, Heimer R, Tirrell S, et al. Diarrhoeagenic Escherichia coli infection in Baltimore, Maryland and New Haven, Connecticut. Clin Infec Dis 2006; 43: 402–7
- Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2: 123–40
- Nataro JP. Enteroaggregative Escherichia coli pathogenesis. Curr Opin Gastroenterol 2005; 21: 4–8
- Nataro JP, Kaper JB. Diarrhoeagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142–201
- National Committee for Clinical Laboratory Standards, 1997. Performance standards for antimicrobial disk susceptibility tests. 6th edn. Wayne, PA: National Committee for Clinical Laboratory Standards. Approved Standard M2-A6.17;1.
- Nataro JP, Kaper JB. Patterns of adherence of diarrhoeagenic Escherichia coli to HEp-2 cells. Pediatr Infec Dis J 1987; 6: 829–31
- Pass MA, Odedra R, Batt RM. Multiplex PCRs for identification of Escherichia coli virulence genes. J Clin Microbiol 2000; 38: 2001–4
- Garcia TE, Cerna JF, Gill LP, Ralázquez RF, Ochoa TJ, Orres JT, et al. Drug resistant diarrhoeagenic Escherichia coli, Mexico. Emerg Infec Dis 2005; 11(8)1306–8
- Trabulsi LR, Keller R, Tardelli Gomes TA. Typical and atypical enteropathogenic Escherichia coli. Emerg Infect Dis 2002; 8: 508–13
- Vu Ngugen T, Le Van P, Le CH, Ngugen Gia K, Weintraub A. Antibiotic resistance in diarrhoeagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam. Antimicrob Agents Chemother 2005; 49: 816–9
- Wilson A, Evans J, Chart H. Characterization of strains of enteroaggregative Escherichia coli isolated during an infectious intestinal disease study in England. Euro J Epidemiol 2001; 17: 1125–30
- Yamamoto T, Echeverria P, Yokota T. Drug resistance and adherence to human intestines of enteroaggregative Escherichia coli. J Infect Dis 1992; 165: 744–9